UnitedHealth Group Incorporated vs Veeva Systems Inc. — Stock Comparison
Q·Score Breakdown
6.3
Neutral
Overall
8.9
Very Bullish
Quality
Health
Growth
Valuation
Sentiment
UNH
82% of 28 covering analysts have a positive rating.
⚠ limited growth momentum.
VEEV
Clean balance sheet with low leverage (0.0× debt-to-equity).
Analyst Consensus
BUY
Target $387.27 (+5.0%)
26 analysts
BUY
Target $264.46 (+54.1%)
28 analysts
Fundamentals
UNH
VEEV
27.9×
Trailing P/E
31.5×
17.8×
Forward P/E
17.4×
2.7%
Profit Margin
28.4%
18.8%
Gross Margin
75.5%
12.2%
ROE
13.9%
2.0%
Revenue Growth
16.0%
0.7%
Earnings Growth
23.2%
0.41
Beta
1.10
—
Price / Book
—
$334.9B
Market Cap
$28.2B
$235 – $410
52-Week Range
$148 – $311
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →